A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
| Egile nagusia: | |
|---|---|
| Beste egile batzuk: | |
| Formatua: | Thesis |
| Hizkuntza: | English |
| Argitaratua: |
Brac University
2024
|
| Gaiak: | |
| Sarrera elektronikoa: | http://hdl.handle.net/10361/24298 |